A/Professor Howard Gurney
Howard Gurney is the Head of Clinical Research for Medical Oncology, Westmead Hospital and Clinical Associate Professor of the Faculty of Medicine, University of Sydney.
Dr Gurney has a firm background in clinical research and has subspecialty interests in lymphoma and uro-genital cancers including prostate, bladder, testis and kidney cancer.
He has been principle investigator for over 150 phase 2 and 3 clinical studies. Current research interests include the pharmacogenomics of chemotherapy and targeted therapies and he has published widely in this area. He is regarded as a world authority on mechanisms for safe dosing of anticancer agents and has written a number of invited editorials on this topic for Lancet Oncology and the Journal of Clinical Oncology.